Machine learning analysis of pregnancy data enables early identification of a subpopulation of newborns with ASD.

Journal: Scientific reports
Published Date:

Abstract

To identify newborns at risk of developing ASD and to detect ASD biomarkers early after birth, we compared retrospectively ultrasound and biological measurements of babies diagnosed later with ASD or neurotypical (NT) that are collected routinely during pregnancy and birth. We used a supervised machine learning algorithm with a cross-validation technique to classify NT and ASD babies and performed various statistical tests. With a minimization of the false positive rate, 96% of NT and 41% of ASD babies were identified with a positive predictive value of 77%. We identified the following biomarkers related to ASD: sex, maternal familial history of auto-immune diseases, maternal immunization to CMV, IgG CMV level, timing of fetal rotation on head, femur length in the 3rd trimester, white blood cell count in the 3rd trimester, fetal heart rate during labor, newborn feeding and temperature difference between birth and one day after. Furthermore, statistical models revealed that a subpopulation of 38% of babies at risk of ASD had significantly larger fetal head circumference than age-matched NT ones, suggesting an in utero origin of the reported bigger brains of toddlers with ASD. Our results suggest that pregnancy follow-up measurements might provide an early prognosis of ASD enabling pre-symptomatic behavioral interventions to attenuate efficiently ASD developmental sequels.

Authors

  • Hugues Caly
    Gynecology-Obstetrics Department, Mère-Enfant Hospital, University Hospital Center, Limoges, France.
  • Hamed Rabiei
    BABiomedical, Luminy Scientific Campus, Marseille, France.
  • Perrine Coste-Mazeau
    Gynecology-Obstetrics Department, Mère-Enfant Hospital, University Hospital Center, Limoges, France.
  • Sebastien Hantz
    Bacteriology-Virology-Hygiene Department, University Hospital Center, Limoges, France.
  • Sophie Alain
    CNR des cytomegalovirus, laboratoire de bactériologie, virologie et hygiène, CHU Dupuytren, Limoges, France.
  • Jean-Luc Eyraud
    Gynecology-Obstetrics Department, Mère-Enfant Hospital, University Hospital Center, Limoges, France.
  • Thierry Chianea
    Department of Biochemistry and Molecular Genetics, Dupuytren University Hospital, Limoges, France.
  • Catherine Caly
    Gynecology-Obstetrics Department, Mère-Enfant Hospital, University Hospital Center, Limoges, France.
  • David Makowski
    INRAE, UMR MIA 518, INRA AgroParisTech Université Paris-Saclay, Paris, France.
  • Nouchine Hadjikhani
    Martinos Center for Biomedical Imaging, Harvard Medical School, Boston, USA.
  • Eric Lemonnier
    Autism Expert Center and Autism Resource Center of Limousin, University Hospital Center, Limoges, France.
  • Yehezkel Ben-Ari
    BABiomedical, Luminy Scientific Campus, Marseille, France. ben-ari@neurochlore.fr.